195 related articles for article (PubMed ID: 18384512)
1. Neuronal toxicity of expanded polyglutamine depends on intracellular distribution in addition to the expression level.
Satoh M; Shimada A; Kawamura N; Chiba Y; Yoshikawa K; Ishii S; Furukawa A; Kumagai N; Hosokawa M
Neuropathology; 2008 Oct; 28(5):485-96. PubMed ID: 18384512
[TBL] [Abstract][Full Text] [Related]
2. Polyglutamine-mediated aggregation and cell death.
de Cristofaro T; Affaitati A; Feliciello A; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 2000 Jun; 272(3):816-21. PubMed ID: 10860836
[TBL] [Abstract][Full Text] [Related]
3. Time course of polyglutamine aggregate body formation and cell death: enhanced growth in nucleus and an interval for cell death.
Toyoshima I; Sugawara M; Kato K; Wada C; Shimohata T; Koide R; Onodera O; Tsuji S
J Neurosci Res; 2002 May; 68(4):442-8. PubMed ID: 11992470
[TBL] [Abstract][Full Text] [Related]
4. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
[TBL] [Abstract][Full Text] [Related]
6. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
[TBL] [Abstract][Full Text] [Related]
7. The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates.
de Cristofaro T; Affaitati A; Cariello L; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 1999 Jun; 260(1):150-8. PubMed ID: 10381359
[TBL] [Abstract][Full Text] [Related]
8. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
Yamada M; Tan CF; Inenaga C; Tsuji S; Takahashi H
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):665-75. PubMed ID: 15541006
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
Huynh DP; Figueroa K; Hoang N; Pulst SM
Nat Genet; 2000 Sep; 26(1):44-50. PubMed ID: 10973246
[TBL] [Abstract][Full Text] [Related]
10. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.
Hirabayashi M; Inoue K; Tanaka K; Nakadate K; Ohsawa Y; Kamei Y; Popiel AH; Sinohara A; Iwamatsu A; Kimura Y; Uchiyama Y; Hori S; Kakizuka A
Cell Death Differ; 2001 Oct; 8(10):977-84. PubMed ID: 11598795
[TBL] [Abstract][Full Text] [Related]
11. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor.
Kim WY; Fayazi Z; Bao X; Higgins D; Kazemi-Esfarjani P
Mol Cell Neurosci; 2005 Aug; 29(4):536-44. PubMed ID: 15936212
[TBL] [Abstract][Full Text] [Related]
12. On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3.
Seidel K; Siswanto S; Fredrich M; Bouzrou M; den Dunnen WFA; Özerden I; Korf HW; Melegh B; de Vries JJ; Brunt ER; Auburger G; Rüb U
Brain Pathol; 2017 May; 27(3):345-355. PubMed ID: 27377427
[TBL] [Abstract][Full Text] [Related]
13. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mutant mice that express polyglutamine in cerebellar Purkinje cells.
Oue M; Mitsumura K; Torashima T; Koyama C; Yamaguchi H; Furuya N; Hirai H
Brain Res; 2009 Feb; 1255():9-17. PubMed ID: 19103174
[TBL] [Abstract][Full Text] [Related]
15. PolyQ fibrillation in the cell nucleus: who's bad?
von Mikecz A
Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
[TBL] [Abstract][Full Text] [Related]
16. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
Klejbor I; Stachowiak EK; Bharali DJ; Roy I; Spodnik I; Morys J; Bergey EJ; Prasad PN; Stachowiak MK
J Neurosci Methods; 2007 Sep; 165(2):230-43. PubMed ID: 17655935
[TBL] [Abstract][Full Text] [Related]
17. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
Furusho K; Yoshizawa T; Shoji S
Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
[TBL] [Abstract][Full Text] [Related]
18. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases.
Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M
Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases.
Chen M; von Mikecz A
Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Maat-Schieman ML; Hobo B; de Vos RA; Brunt ER; Hol EM; Roos RA; van Leeuwen FW
Hum Mol Genet; 2004 Aug; 13(16):1803-13. PubMed ID: 15198995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
